AXGN 16,89$ (-21%)

hi, ist die Aktie jetzt ein Kauf oder fundamental ueberbewertet,jedenfalls geht der aktuelle meltdown bei allen biotechs an axogen scheinbar vorueber,aktie zumindest stabil .... [mehr]

axogen keine nerven ?

axogen keine nerven ?, beschaedigte oder abgetrennte nerven koennenn offenbar wider zusammengefuegt werden,dank dieser aktie: Axogen Aces Phase 3 Study For Avance Nerve Graft Vandana Singh Thu, May 5, 2022, 4:58 PM In this article: Axogen Inc (NASDAQ: AXGN) announced topline results from its RECON Clinical Study comparing Avance Nerve Graft to conduits in digital nerve injuries. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. The Phase 3 pivotal study met its primary endpoint for the return of sensory function as measured by static two-point discrimination, and the safety profile was consistent with previously published data. This data will support the company's US marketing application in 2H 2023. Avance demonstrated statistical superiority for return of sensory function (measured by static two-point discrimination) com [mehr]

aktiencheck.de - Forum - Axogen Inc

AXGN 16,89$ (-21%)

axogen keine nerven ?